Articles published by Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
August 03, 2023
From
Alnylam Pharmaceuticals
Via
Business Wire
Tickers
ALNY
Alnylam Reports Updated Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
July 17, 2023
From
Alnylam Pharmaceuticals
Via
Business Wire
Tickers
ALNY
Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day
December 15, 2022
From
Alnylam Pharmaceuticals
Via
Business Wire
Tickers
ALNY
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.